Toxin-Induced Seizures

Haley N Phillips1, Laura Tormoehlen2

  • 1Department of Neurology, Indiana University, Indiana University Neuroscience Center, 355 West 16th Street, Suite 4700, Indianapolis, IN 46202, USA.

Neurologic Clinics
|October 12, 2020
PubMed

Insights

This review covers common toxins causing seizures, their mechanisms, and treatments. Understanding these toxic seizures aids in predicting and managing future poisoning cases.

Area of Science:

  • Toxicology
  • Neurology
  • Emergency Medicine

Background:

  • Emerging toxins pose a continuous threat.
  • Seizures are a critical manifestation of various toxic exposures.
  • Understanding toxin-induced seizures is crucial for clinical management.

Purpose of the Study:

  • To review common toxins that induce seizures.
  • To elucidate the mechanisms underlying toxin-induced seizures.
  • To describe associated toxidromes and treatment strategies.

Main Methods:

  • Literature review of common seizure-inducing toxins.
  • Analysis of mechanisms of action for each toxin class.
  • Compilation of clinical toxidromes and management guidelines.

Main Results:

  • Stimulants, cholinergic agents, GABA antagonists, glutamate agonists, histamine/adenosine antagonists, and withdrawal states are key toxin categories.
  • Specific mechanisms involve neurotransmitter system disruption.
  • Toxidromes and targeted treatments are detailed for each category.

Conclusions:

  • A comprehensive understanding of current toxin-induced seizure mechanisms is essential.
  • This knowledge facilitates prediction and management of future poisoning-related seizures.
  • Effective treatment relies on accurate identification of the causative toxin and its mechanism.

Related Concept Videos

Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
1.1K
Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
991
Types of Toxins01:36

Types of Toxins

Humans continually engage with an environment rich in potentially harmful chemicals. These are introduced to our bodies through inhalation, ingestion, or skin contact. These chemicals exist in various forms, such as air and environmental pollutants, agricultural chemicals, organic solvents, and heavy metals.
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
3.0K
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
670
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
487
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
1.0K